Targeted modification of cis-elements in the CUL3 gene to restore exon 9 inclusion for treating Gordon syndrome
Authors:
Open Access
- 21 October 2025
- journal article
- research article
- Published by Springer Nature in Human Genomics
- Vol. 19 (1) , 1-15
Abstract
The weak splice acceptor site (AS) of exon 9 underlies almost all pathogenic variants of Cullin3 (CUL3) causing exon 9 skipping in Gordon syndrome, emphasizing the need for splicing-targeted therapeutic strategies. This study explored universal therapeutic targets to modulate AS and investigated their potential and mechanisms for restoring normal splicing. Through bioinformatic prediction, minigene assays, EMSA, CRISPR/Cas9-mediated construction of mutant cell lines and RIP, three rescue sites in the polypyrimidine (Py) tract of intron 8 were identified, including A(-9)T, A(-10)T and AA(-9, -10)TT, with AA(-9, -10)TT most effectively promoting exon inclusion by extending the Py-tract to increase U2AF2 binding. Additionally, previous candidate target A18G was confirmed to rescue exon 9 skipping by weakening hnRNP A1 splicing inhibition in endogenous cell models. Our findings highlight the therapeutic potential of AA(-9, -10)TT and A18G in CUL3-related Gordon syndrome, suggesting the targeted modification of cis-elements could be an ideal and universal strategy to develop treatments for splicing-related diseases.Keywords
Funding Information
- the Shandong Province Natural Science Foundation (ZR2022MH300)
- The National Natural Science Foundation of China (82271540)
- the Natural Science Foundation of the Affiliated Hospital of Qingdao University (QDFY+X2024131)
This publication has 63 references indexed in Scilit:
- Minigene splicing assays reveal new insights into exonic variants of the SLC12A3 gene in Gitelman syndromeMolecular Genetics & Genomic Medicine, 2023
- Vulnerable exons, like ACADM exon 5, are highly dependent on maintaining a correct balance between splicing enhancers and silencersHuman Mutation, 2021
- Identification of seven exonic variants in the SLC4A1 , ATP6V1B1 , and ATP6V0A4 genes that alter RNA splicing by minigene assayHuman Mutation, 2021
- Splicing mutations in human genetic disorders: examples, detection, and confirmationJournal of Applied Genetics, 2018
- A novel mutation in exon 9 of Cullin 3 gene contributes to aberrant splicing in pseudohypoaldosteronism type IIFEBS Open Bio, 2018
- Pre-mRNA mis-splicing of sarcomeric genes in heart failureBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2017
- Modulation of aberrant splicing in human RNA diseases by chemical compoundsHuman Genetics, 2017
- CUL3 gene analysis enables early intervention for pediatric pseudohypoaldosteronism type II in infancyPediatric Nephrology, 2013
- Targeting RNA splicing for disease therapyWIREs RNA, 2013
- Silencers regulate both constitutive and alternative splicing events in mammalsCellular and Molecular Life Sciences, 2005